腹腔镜与开腹肝部分切除术治疗肝细胞癌临床疗效比较 |
| |
引用本文: | 古建辉,李云涛,张国云. 腹腔镜与开腹肝部分切除术治疗肝细胞癌临床疗效比较[J]. 海南医学, 2016, 0(9): 1426-1428. DOI: 10.3969/j.issn.1003-6350.2016.09.018 |
| |
作者姓名: | 古建辉 李云涛 张国云 |
| |
作者单位: | 1. 成都市第三人民医院 重庆医科大学附属成都第二临床学院普外科,四川 成都,610031;2. 文山市人民医普外科,云南 文山,663000 |
| |
基金项目: | 云南省文山市科研基金项目资助(2014WS017) |
| |
摘 要: | 目的 探讨腹腔镜与开腹肝部分切除术治疗肝细胞癌的临床疗效及安全性.方法 选取2008年1月至2013年6月成都市第三人民医院收治手术治疗的原发性肝细胞癌患者84例为研究对象,其中腹腔镜下肝癌肝部分切除术者41例(腹腔镜组),开腹肝癌肝部分切除术者43例(开腹组),比较两组患者的手术时间、术中出血量、术后住院时间、手术费用及术后生存率.结果 腹腔镜组手术时间明显长于开腹组[(88.54±28.32)minvs(59.24±19.52)min],住院时间明显短于开腹组[(13.23±3.65)d vs(17.21±6.45)d],差异均有统计学意义(P<0.05);而术中失血量[(502.66±105.32)mL vs(479.63±112.16)mL]、肝门阻断时间[(22.36±10.32)min vs(19.36±11.45)min]、住院费用[(3.45±0.21)万元vs(3.39±0.23)万元]和并发症[9.8%(4/41)vs 9.3%(4/43)]比较差异均无统计学意义(P>0.05);腹腔镜组1年和2年生存率为88.1%和76.1%,开腹组为90.0%和72.5%,两组1年和2年生存率比较差异均无统计学意义(P>0.05);腹腔镜组中位生存时间为50.2个月,开腹为46.5个月,两组患者中位生存时间比较差异无统计学意义(P>0.05).结论 腹腔镜治疗原发性肝细胞癌创伤小,术后恢复快,但手术时间较长.
|
关 键 词: | 腹腔镜 开腹手术 肝细胞癌 临床疗效 安全性 |
Clinical comparative study of laparoscopic hepatectomy versus open hepatectomy for the treatment of hepatocellular carcinoma |
| |
Abstract: | Objective To evaluate the clinical efficacy and safety of laparoscopic versus open hepatectomy in the treatment of hepatocellular carcinoma (HCC). Methods Eighty-four patients of primary HCC, who admitted to the Third People's Hospital of Chengdu from January 2008 to June 2013, were analyzed in this study. Of these, 41 patients-were treated by laparoscopic hepatectomy (laparoscopic hepatectomy group), and other 43 patients were treated by open hepatectomy (open hepatectomy group). The operation time, blood loss, length of hospital stay, hospitalization expenses, complications and median survival time of the two groups were compared. Results The operation time of laparoscopic hepatectomy group was significantly longer than open hepatectomy group [(88.54±28.32) min vs (59.24±19.52) min, P<0.05], while the length of hospital stay in laparoscopic hepatectomy group was significantly shorter than open hepatectomy group [(13.23 ± 3.65) days vs (17.21 ± 6.45) days, P<0.05]. The blood loss [(502.66 ± 105.32) mL vs (479.63 ± 112.16) mL], pringle's manoeuver time [(22.36 ± 10.32) min vs (19.36 ± 11.45) min], hospitalization expenses [(3.45 ± 0.21) × 105 ¥ vs (3.39±0.23)×105 ¥] and complication incidence [9.8%(4/41) vs 9.3%(4/43)] of the two groups had no significant differ-ences (P>0.05). The 1-year and 2-year survival rates in the laparoscopic hepatectomy group and open hepatectomy group were respectively 88.1%and 76.1%versus 90.0%and 72.5%, with no significant difference (P>0.05). The median survival time of the laparoscopic hepatectomy group and open hepatectomy group were respectively 50.2 months and 46.5 months, with no significant difference (P>0.05). Conclusion Laparoscopic hepatectomy had the advantages of minimal trauma and rapid postoperative recovery, but the operation time was relatively long for the treatment of HCC. |
| |
Keywords: | Laparoscope Open surgery Hepatocellular carcinoma Clinical efficacy Safety |
本文献已被 万方数据 等数据库收录! |
|